Items where authors include "Szer, J"
Article
Brodsky, RA, Peffault de Latour, R, Rottinghaus, ST et al. (15 more authors) (2020) Characterization of breakthrough hemolysis events observed in the phase 3 randomized studies of ravulizumab versus eculizumab in adults with paroxysmal nocturnal hemoglobinuria. Haematologica. ISSN 0390-6078
Hillmen, P orcid.org/0000-0001-5617-4403, Muus, P, Röth, A et al. (11 more authors) (2013) Long‐term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal haemoglobinuria. British Journal of Haematology, 162 (1). pp. 62-73. ISSN 0007-1048
Conference or Workshop Item
Roeth, A, Hillmen, P orcid.org/0000-0001-5617-4403, Szer, J et al. (16 more authors) (2020) Results of the PEGASUS phase 3 randomized trial demonstrating superiority of the C3 inhibitor, pegcetacoplan, compared to eculizumab in patients with paroxysmal nocturnal hemoglobinuria (PNH). In: Conference of the German, Austrian and Swiss Societies for Hematology and Medical Oncology, 09-11 Oct 2020, Online.
Proceedings Paper
Peffault De Latour, R, Mitchell, L, Brodsky, RA et al. (10 more authors) (2019) Ravulizumab (ALXN1210) versus eculizumab in adults with paroxysmal nocturnal hemoglobinuria: pharmacokinetics and pharmacodynamics observed in two Phase 3 randomized, multicenter studies. In: British Journal of Haematology. 59th Annual Scientific Meeting of the British Society for Hematology, 01-03 Apr 2019, Glasgow, UK. Wiley , p. 110.